Literature DB >> 3174271

Infants with cystic fibrosis: pulmonary function at diagnosis.

R S Tepper1, P Hiatt, H Eigen, P Scott, J Grosfeld, M Cohen.   

Abstract

Meconium ileus (MEC), failure to thrive (FTT), and a combination of FTT and pulmonary symptoms (COMB) are the most frequent symptoms of cystic fibrosis (CF) at the time of diagnosis. The purpose of this study was to compare to normal controls (NC) the pulmonary function of CF infants at the time of diagnosis, when grouped by these symptoms. The measurements of pulmonary function included oxygen saturation (SaO2), functional residual capacity (FRC), mixing index (MI), total respiratory system compliance (Crs), and maximal flow at FRC (VmaxFRC). Compared to NC (n = 33), the MEC group (n = 5) had a higher MI (54 vs. 42%) and no difference in SaO2, Crs or VmaxFRC. There were no significant differences between FTT (n = 8) and NC groups although there was a tendency for Crs to be lower in the FTT group (5.1 vs. 6.8 ml/cm H2O). When compared to all other groups, the COMB group (n = 11) had significantly lower SaO2, MI, Crs, and VmaxFRC. The normal lung function in the MEC group is consistent with the normal anatomy reported in CF infants dying secondary to meconium ileus. Longitudinal evaluation of the infants in this study, following initiation of care as patients with a diagnosis of CF, may allow us to determine whether symptoms at diagnosis remain an important determinant of lung function in infancy.

Entities:  

Mesh:

Year:  1988        PMID: 3174271     DOI: 10.1002/ppul.1950050105

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  11 in total

1.  High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis.

Authors:  Tanya M Martínez; Conrado J Llapur; Tamica H Williams; Cathy Coates; Richard Gunderman; Mervyn D Cohen; Michelle S Howenstine; Osama Saba; Harvey O Coxson; Robert S Tepper
Journal:  Am J Respir Crit Care Med       Date:  2005-07-28       Impact factor: 21.405

2.  Nocturnal oximetry in infants with cystic fibrosis.

Authors:  M P Villa; J Pagani; V Lucidi; S Palamides; R Ronchetti
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

3.  Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests.

Authors:  Sooky Lum; Per Gustafsson; Henrik Ljungberg; Georg Hülskamp; Andrew Bush; Siobhán B Carr; Rosemary Castle; Ah-Fong Hoo; John Price; Sarath Ranganathan; John Stroobant; Angie Wade; Colin Wallis; Hilary Wyatt; Janet Stocks
Journal:  Thorax       Date:  2006-11-22       Impact factor: 9.139

Review 4.  Monitoring early inflammation in CF. Infant pulmonary function testing.

Authors:  Jack K Sharp
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

5.  Early airway infection, inflammation, and lung function in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood; Claire Wainwright
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

6.  Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment.

Authors:  C S Beardsmore; J R Thompson; A Williams; E K McArdle; G A Gregory; L T Weaver; H Simpson
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

7.  Lung function from infancy to school age in cystic fibrosis.

Authors:  C S Beardsmore
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

Review 8.  Endpoints for clinical trials in young children with cystic fibrosis.

Authors:  Stephanie D Davis; Alan S Brody; Mary J Emond; Lyndia C Brumback; Margaret Rosenfeld
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

9.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

Review 10.  Advantages of comprehensive lung function techniques in cystic fibrosis.

Authors:  C K van der Ent; P L Brand
Journal:  J R Soc Med       Date:  1999       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.